Mesa Laboratories (FRA:MLI) Total Liabilities : €310.7 Mil (As of Dec. 2023)

View and export this data going back to 2019. Start your Free Trial

What is Mesa Laboratories Total Liabilities?

Mesa Laboratories's Total Liabilities for the quarter that ended in Dec. 2023 was €310.7 Mil.

Mesa Laboratories's quarterly Total Liabilities declined from Jun. 2023 (€235.27 Mil) to Sep. 2023 (€233.72 Mil) but then increased from Sep. 2023 (€233.72 Mil) to Dec. 2023 (€310.69 Mil).

Mesa Laboratories's annual Total Liabilities increased from Mar. 2021 (€164.01 Mil) to Mar. 2022 (€284.72 Mil) but then declined from Mar. 2022 (€284.72 Mil) to Mar. 2023 (€250.64 Mil).

Mesa Laboratories Total Liabilities Historical Data

The historical data trend for Mesa Laboratories's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mesa Laboratories Total Liabilities Chart

Mesa Laboratories Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Total Liabilities

Get a 7-Day Free Trial

40.23

171.13

164.01

284.72

250.64

Mesa Laboratories Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Total Liabilities	Get a 7-Day Free Trial															260.34	250.64	235.27	233.72	310.69

Mesa Laboratories Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Mesa Laboratories's Total Liabilities for the fiscal year that ended in Mar. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	40.497	+	(171.176	+	7.186
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	31.782	+	0)
	=	250.6

Total Liabilities	=	Total Assets (A: Mar. 2023 )	-	Total Equity (A: Mar. 2023 )
	=	618.151	-	367.51
	=	250.6

Mesa Laboratories's Total Liabilities for the quarter that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	40.516	+	(213.629	+	15.882
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	40.66	+	0)
	=	310.7

Total Liabilities	=	Total Assets (Q: Dec. 2023 )	-	Total Equity (Q: Dec. 2023 )
	=	680.202	-	369.515
	=	310.7

Mesa Laboratories Total Liabilities Related Terms

Thank you for viewing the detailed overview of Mesa Laboratories's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Mesa Laboratories (FRA:MLI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Technology » Hardware » Mesa Laboratories Inc (FRA:MLI) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

MLAB:USA

Address

12100 West Sixth Avenue, Lakewood, CO, USA, 80228

Website

https://www.mesalabs.com

Mesa Laboratories Inc manufactures life sciences tools and critical quality control products. It operates in 4 divisions: Sterilization and Disinfection Control, which manufactures and sells biological, cleaning, and chemical indicators. It also provides testing and laboratory services, mainly to the dental industry; Biopharmaceutical Development segment develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions; Calibration Solutions division develops, manufactures, and sells quality control and calibration products used to measure or calibrate temperature, pressure, pH, humidity, and other such parameters for health and safety purposes; and Clinical Genomics. Its geographical segments include United States and Foreign.